ClinConnect ClinConnect Logo
Search / Trial NCT06369753

Visible Abdominal Distension

Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Apr 12, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people who experience visible abdominal distension, which is when the stomach becomes noticeably swollen after meals. The researchers want to see if a simple biofeedback technique, which teaches patients how to control their abdominal muscles, can effectively reduce this discomfort. In the trial, participants will be randomly assigned to either receive the biofeedback training or a placebo (which is an inactive treatment) for four weeks.

To be eligible for this trial, participants should be between the ages of 18 and 75 and must have episodes of visible abdominal swelling that happen after eating. However, they need to have no underlying medical conditions that could explain their symptoms, such as constipation or other health issues identified by their doctor. During the study, participants will attend three training sessions and practice the techniques at home before meals. This trial aims to see if this easy-to-follow method can help improve the quality of life for those dealing with embarrassing and uncomfortable bloating.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • episodes of visible abdominal distension triggered by meal ingestion
  • Exclusion Criteria:
  • organic cause detected by clinical work-up
  • constipation
  • abdominal distension not confirmed by the 7-day clinical questionnaires in the pre- intervention evaluation

About Hospital Universitari Vall D'hebron Research Institute

The Hospital Universitari Vall d'Hebron Research Institute (VHIR) is a leading biomedical research center affiliated with Vall d'Hebron University Hospital in Barcelona, Spain. Committed to advancing healthcare through innovative research, VHIR focuses on translating scientific discoveries into clinical applications, enhancing patient care and outcomes. The institute fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, emphasizing excellence in translational medicine, clinical trials, and public health initiatives. With a strong emphasis on ethical standards and patient safety, VHIR is dedicated to contributing to the global body of knowledge in various medical fields.

Locations

Barcelona, , Spain

Bordeaux, , France

Los Angeles, California, United States

Hamilton, Ontario, Canada

Bologna, , Italy

Gothenburg, , Sweden

Manchester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Fernando Azpiroz, MD

Principal Investigator

University Hospital Vall d'Hebron

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported